Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Amiodarone is the most widely prescribed antiarrhythmic drug worldwide, but induces thyrotoxicosis or hypothyroidism in 15 to 20% of patients. Hyperthyroidism is less frequent than hypothyroidism, and two types of thyrotoxicosis are distinguished according to presence of underlying thyroid disease. Diagnosis is made in case of low TSH and high levels of T3 and T4. Initial treatment is based on anti-thyroid drugs and/or glucocorticoids. Some patients do not respond to medication, which increases the time spent with hyperthyroidism. A long interval between diagnosis and euthyroidism and low left ventricular ejection fraction (LVEF) are predictive of major adverse cardiovascular events. Here, after describing the current state of knowledge of amiodarone-induced thyrotoxicosis, we analyze the literature on the impact of surgery. We suggest that early surgery should be the first option in case of ineffective medical treatment or LVEF<40%. In expert centers, surgical morbidity is no longer different than in other indications for thyroidectomy. Copyright © 2024 Elsevier Masson SAS. All rights reserved.

Citation

Samuel Frey, Cécile Caillard, Pascale Mahot, Delphine Drui, Eric Mirallié. Amiodarone-induced thyrotoxicosis: Should surgery be considered? Annales d'endocrinologie. 2024 Apr;85(2):136-141

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 38246417

View Full Text